- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
John C. Richter
News 14 results
Recognition
October 13, 2021
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Recognition
October 5, 2021
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2021 Guide
In the News · Source: Law360
May 18, 2021
John Richter advises AT&T on its settlement with the District of Columbia
Recognition
October 23, 2020
GIR Names King & Spalding to List of Top 30 Global Investigations Firms for Sixth Year
Events 13 results
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Speaking Engagement
November 6, 2019
John Richter, Richard Walker, Nikki Reeves to Speak at 20th Annual Pharmaceutical and Medical Device Compliance Congress
Conference
September 5, 2019
12th Annual Medical Device Summit
Insights 28 results
Article · Source: Chamber Litigation Blog
August 12, 2021
Top False Claims Act Developments
Feature
February 10, 2021
General Counsel Internal Investigations Decision Tree for the Automotive Industry
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Energy Industry
Feature
January 15, 2021
General Counsel’s Decision Tree